食色app下载

scroll down

* The search scope is limited to the products and news sections of this site

Recommended reading

Bayer: Encouraging results for all divisions-Agreement signed to divest Currenta and animal health businesses

Financial Results for the Third Quarter of 2019

Learn more>
image
Globally superior ophthalmic anti-VEGF drug Elias® dual indications are officially listed in the National Medical Insurance Directory

Learn more>
image

Bayer Elias® treatment interval can be extended to 3 months, and its new treatment plan is available in China

Learn more>
image

Bayer Leap plans to lead $ 215 million investment in research and development of next-generation immune tumor treatment

Learn more>
image

US FDA approves darolutamide, a new treatment for non-metastatic castration-resistant prostate cancer

Learn more>
image

Bayer Planning Vision looks to the future of agriculture

Learn more>
image

The latest news from Bayer

Stock price / index

XETRA December 30, 2019 14:05 CEST
72.81
-0.55 % down -0.55%
DAX December 30, 2019 14:15 CEST
13,249.01
-0.66 % down -0.66%

News Center

2019-12-10

Bayer will further increase sustainable development efforts and announce comprehensive measures for sustainable development by 2030

understand more
2019-12-03

Bayer submits application of rivaroxaban for venous thromboembolism in children to European Medicines Agency

understand more
2019-12-02

Bayer China awarded "China Outstanding Employer 2020" certification

understand more

Our business

Our products are helping to solve some of today's toughest challenges, including global population growth, an aging society, and the need to be efficient-and where possible sustainable-to use natural resources.

image
image
image
image

Find what you need

Our products focus on the health of people, animals and plants. Here you can find an overview of Bayer's main products in China.

Last updated: 2019-12-17

For questions about Bayer products, you can contact us at:


Hotline: 400-810-0360 (can be dialed from mobile phones)


We will try our best to answer your inquiries about Bayer products, but we are unable to make specific diagnosis and treatment recommendations for the patient's current condition. If you experience discomfort after taking this medicine, be sure to see your doctor promptly.


For use after reporting discomfort or Bayer products, product quality problems, contact your doctor or local pharmacist and drug regulatory authorities, you can also contact us directly by the following ways.


Email: AE_China@bayer.com
Online report: http://safetrack-public.bayer.com


If you encounter Bayer Animal Health veterinary products in the process of adverse reactions issue, you can contact us by:


Email: pv.bsah@bayer.com


shut down